VistaGen Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: VistaGen Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: VistaGen Therapeutics Inc
Rating: 2.01725
Author: Trendlyne DVM scores

about

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neur...

3.57 -0.04 (-1.11%)

New 52W High in past week

161.9K

XNAS Volume

XNAS 10 Sep, 2025 3:59 PM (EDT)

Not Eligible

Expensive Valuation

11.5 / 100

Technically Moderately Bullish

69.2 / 100

1Yr Price target upside is 306%

4 analysts

VistaGen Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VistaGen Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neur...

New 52W High in past week

SWOT Analysis

VistaGen Therapeutics Inc Live Price Chart